185 related articles for article (PubMed ID: 29094256)
1. Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.
Chen S; Li R; Lu L; Duan L; Zhang X; Tong A; Pan H; Zhu H; Lu Z
Endocrine; 2018 Jan; 59(1):183-190. PubMed ID: 29094256
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of efficacy between the serum cortisol and 24 hour urine free cortisol in combined dexamethasone suppression test in the diagnosis of Cushing syndrome].
Lu L; Chen JH; Zhu HJ; Song AL; Li M; Chen S; Pan H; Gong FY; Wang RZ; Xing B; Yao Y; Feng M; Lu ZL
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2150-4. PubMed ID: 27464539
[TBL] [Abstract][Full Text] [Related]
3. An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other.
Tung SC; Hwang DY; Yang JW; Chen WJ; Lee CT
Endocr J; 2012; 59(9):823-30. PubMed ID: 22785148
[TBL] [Abstract][Full Text] [Related]
4. The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias.
Xu Y; Rui W; Qi Y; Zhang C; Zhao J; Wang X; Wu Y; Zhu Q; Shen Z; Ning G; Zhu Y
World J Surg; 2013 Jul; 37(7):1626-32. PubMed ID: 23592061
[TBL] [Abstract][Full Text] [Related]
5. An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome Based on Low-Dose Dexamethasone Suppression Test.
Chen K; Chen S; Lu L; Zhu H; Zhang X; Tong A; Pan H; Wang R; Lu Z
Front Endocrinol (Lausanne); 2021; 12():720823. PubMed ID: 34539574
[TBL] [Abstract][Full Text] [Related]
6. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
Dias R; Storr HL; Perry LA; Isidori AM; Grossman AB; Savage MO
Horm Res; 2006; 65(3):159-62. PubMed ID: 16514243
[TBL] [Abstract][Full Text] [Related]
7. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
8. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease.
Stratakis CA; Sarlis N; Kirschner LS; Carney JA; Doppman JL; Nieman LK; Chrousos GP; Papanicolaou DA
Ann Intern Med; 1999 Oct; 131(8):585-91. PubMed ID: 10523219
[TBL] [Abstract][Full Text] [Related]
10. UTILITY OF A SINGLE LATE-NIGHT PLASMA CORTISOL AND ACTH FOR THE DIAGNOSIS OF CUSHING SYNDROME.
Jarial KDS; Bhansali A; Mukherjee KK; Pal R; Sharma A; Vashishtha RK; Sukumar SP; Sachdeva N; Walia R
Endocr Pract; 2018 Feb; 24(2):156-162. PubMed ID: 29144801
[TBL] [Abstract][Full Text] [Related]
11. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
12. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
13. [A girl with Cushing's syndrome due to primary pigmented nodular adrenocortical disease].
Bocca G; van Mil EG; Voorhoeve PG; Wijnaendts LC; Delemarre-van de Waal HA
Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2390-3. PubMed ID: 17100132
[TBL] [Abstract][Full Text] [Related]
14. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
[TBL] [Abstract][Full Text] [Related]
15. Black adrenal adenoma: distinction from PPNAD.
Kamalanathan S; Mahesh DM; Muruganandham K; Basu D
BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22761223
[TBL] [Abstract][Full Text] [Related]
16. Diurnal Plasma Cortisol Measurements Utility in Differentiating Various Etiologies of Endogenous Cushing Syndrome.
Tirosh A; Lodish MB; Papadakis GZ; Lyssikatos C; Belyavskaya E; Stratakis CA
Horm Metab Res; 2016 Sep; 48(10):677-681. PubMed ID: 27643448
[TBL] [Abstract][Full Text] [Related]
17. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?
Gunther DF; Bourdeau I; Matyakhina L; Cassarino D; Kleiner DE; Griffin K; Courkoutsakis N; Abu-Asab M; Tsokos M; Keil M; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2004 Jul; 89(7):3173-82. PubMed ID: 15240590
[TBL] [Abstract][Full Text] [Related]
18. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
Hofland J; de Herder WW; Derks L; Hofland LJ; van Koetsveld PM; de Krijger RR; van Nederveen FH; Horvath A; Stratakis CA; de Jong FH; Feelders RA
Eur J Endocrinol; 2013 Jan; 168(1):67-74. PubMed ID: 23065993
[TBL] [Abstract][Full Text] [Related]
19. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses.
Young WF; du Plessis H; Thompson GB; Grant CS; Farley DR; Richards ML; Erickson D; Vella A; Stanson AW; Carney JA; Abboud CF; Carpenter PC
World J Surg; 2008 May; 32(5):856-62. PubMed ID: 18074172
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in ACTH-dependent Cushing's syndrome.
Qiao J; Li J; Zhang W; Wang C; Li J; Jiang S; Tan H; Chen Y; Liu H; Cai B; Yu Y
Endocr J; 2021 Jul; 68(7):839-848. PubMed ID: 33790062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
